Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.

Biochimica et biophysica acta - 1 Dec 2010

Ferrari Patrizia

Abstract excerpt

An innovative approach to the therapy of essential hypertension (EH) and the related complications has been pursued by our group with the aim of defining specific genetic-molecular mechanisms underlying the disease in sub-sets of patients. This approach is anticipated to have a major effect on th...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Blood Pressure
Share to Calmodulin-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials, Phase II as Topic

Share to Ouabain

Share to Sodium

Share to Sodium-Potassium-Exchanging ATPase

Share to src-Family Kinases

Source

Identifiers

PMID: 20083196
DOI: 10.1016/j.bbadis.2010.01.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20083196-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.PMID 20083196Read ↗

Rostafuroxin protects from podocyte injury and proteinuria induced by adducin genetic variants and ouabain.Semantic proximity Read ↗

Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin.Semantic proximity Read ↗

Adducin and hypertension.Semantic proximity Read ↗

Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studies.Semantic proximity Read ↗

Mice expressing ouabain-sensitive α1-Na,K-ATPase have increased susceptibility to pressure overload-induced cardiac hypertrophy.Semantic proximity Read ↗

Impact of volume overload on cardiac connexin-43 and extracellular matrix of normotensive and hypertensive Ren-2 transgenic rats: Effects of treatment with Trandolapril and LosartanSemantic proximity Read ↗

Mineralocorticoid Receptor/Rac1-Driven Podocyte Injury in Fabry Disease: Finerenone and Spironolactone migitate the overactive signaling cascadeSemantic proximity Read ↗

Na(+),K(+)-ATPase isoform selectivity for digitalis-like compounds is determined by two amino acids in the first extracellular loop.Semantic proximity Read ↗

PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.Semantic proximity Read ↗

Catestatin: A Master Regulator of Cardiovascular Functions.Semantic proximity Read ↗

Blood Pressure Elevation of Tubular Specific (P)RR Transgenic Mice and Lethal Tubular Degeneration due to Possible Intracellular Interactions between (P)RR and Alternative Renin Products.Semantic proximity Read ↗

Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.